Pharmacotherapy of Non-Alcoholic Fatty Liver Disease: Updated Data

Effective Pharmacotherapy
doi 10.33978/2307-3586-2020-16-1-70-73
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medforum

Related search

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Headway and Hurdles in Non-Alcoholic Fatty Liver Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2020English

Association of Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease

International Journal of Research in Medical Sciences
2016English

Resistin Levels in Non-Alcoholic Fatty Liver Disease Pathogenesis

Journal of Translational Internal Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy